Surge in Aurobindo Pharma's Active Put Options: 2,765 Contracts at Rs 1100 Strike
Aurobindo Pharma Ltd. has become a highly active stock in the options market, with significant put option trading. Despite recent underperformance and a downward trend, investor participation has surged, evidenced by a substantial increase in delivery volume. The stock is currently trading below key moving averages, indicating bearish sentiment.
Aurobindo Pharma Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most active stocks today, particularly in the options market. The company’s underlying stock, AUROPHARMA, is currently valued at Rs 1098.0. Notably, there has been significant activity in put options, with 2,765 contracts traded at a strike price of Rs 1100, resulting in a turnover of approximately Rs 634.61 lakhs. The open interest stands at 793 contracts, indicating ongoing interest in these options.Today, Aurobindo Pharma has underperformed its sector by 1.69%, continuing a downward trend with a three-day decline of 5.17%. The stock reached an intraday low of Rs 1088, reflecting a drop of 4.54%. Furthermore, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish sentiment.
Despite the challenges, there has been a notable increase in investor participation, with delivery volume rising by 775.69% compared to the 5-day average. The liquidity remains robust, accommodating trades of up to Rs 3.93 crore. Overall, Aurobindo Pharma's current market dynamics highlight a complex interplay of factors affecting its stock performance and options activity.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
